Alpha Tau Medical Ltd (DRTS) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Alpha Tau Medical Ltd., known for its innovative Alpha DaRT cancer therapy, is set to engage investors at the upcoming Ladenburg Oncology Innovators & Investors Symposium. CFO Raphi Levy will present the company’s groundbreaking advancements, offering insights into their potential impact on the oncology sector. This event presents an opportunity for investors to explore Alpha Tau’s promising approach to cancer treatment.
For further insights into DRTS stock, check out TipRanks’ Stock Analysis page.
